Solid-state NMR sequential assignment of an Amyloid-β(1–42) fibril polymorph

Biomolecular NMR Assignments

Volumn 10, Issue 2, 2016, Pages 269-276

  Ravotti, Francesco ^a   Wälti, Marielle Aulikki ^a   Güntert, Peter ^b,c   Riek, Roland ^a   Böckmann, Anja ^d   Meier, Beat H ^a  

^a ETH ZURICH   (Switzerland)

^b GOETHE UNIVERSITY   (Germany)

^c TOKYO METROPOLITAN UNIVERSITY   (Japan)

^d UNIVERSITÉ DE LYON   (France)

Author keywords

Alzheimer s disease; Amyloid fibrils; Amyloid peptide; Solid state NMR spectroscopy

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; BETA SHEET; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE; PROTEIN MULTIMERIZATION;

AMINO ACID SEQUENCE; AMYLOID BETA-PEPTIDES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION, BETA-STRAND; PROTEIN MULTIMERIZATION;

EID: 84966501365     PISSN: 18742718     EISSN: 1874270X     Source Type: Journal    
DOI: 10.1007/s12104-016-9682-y     Document Type: Article

References (24)

1. Bertini I, Gonnelli L, Luchinat C et al (2011) A new structural model of Aβ40 fibrils. J Am Chem Soc 133:16013–16022. doi:10.1021/ja2035859
2. Böckmann A, Gardiennet C, Verel R et al (2009) Characterization of different water pools in solid-state NMR protein samples. J Biomol NMR 45:319–327. doi:10.1007/s10858-009-9374-3
3. Colvin MT, Silvers R, Frohm B et al (2015) High resolution structural characterization of Aβ 42Amyloid fibrils by magic angle spinning NMR. J Am Chem Soc 137:7509–7518. doi:10.1021/jacs.5b03997
4. Güntert P, Dötsch V, Wider G, Wüthrich K (1992) Processing of multi-dimensional NMR data with the new software PROSA. J Biomol NMR 2:619–629. doi:10.1007/BF02192850
5. Habenstein B, Wasmer C, Bousset L et al (2011) Extensive de novo solid-state NMR assignments of the 33 kDa C-terminal domain of the Ure2 prion. J Biomol NMR 51:235–243. doi:10.1007/s10858-011-9530-4
6. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356. doi:10.1126/science.1072994
7. Huber M, Ovchinnikova OY, Schütz AK et al (2015) Solid-state NMR sequential assignment of Osaka-mutant amyloid-beta (Aβ1-40 E22Δ) fibrils. Biomol NMR Assign 9:7–14. doi:10.1007/s12104-013-9535-x
8. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Müller B (1987) The precursor of alzheimer’s disease amyloid a4 protein resembles a cell-surface receptor. Nature 325:733–736. doi:10.1038/325733a0
9. Lu J-X, Qiang W, Yau W-M et al (2013) Molecular structure of beta-amyloid fibrils in alzheimer’s disease brain tissue. Cell 154:1257–1268. doi:10.1016/j.cell.2013.08.035
10. Masters CL, Simms G, Weinmann NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in alzheimer disease and down syndrome. Proc Natl Acad Sci USA 82:4245–4249. doi:10.1097/00005072-198505000-00178
11. Meier BH, Böckmann A (2015) The structure of fibrils from “misfolded” proteins. Curr Opin Struct Biol 30:43–49. doi:10.1016/j.sbi.2014.12.001
12. Mithu VS, Sarkar B, Bhowmik D, et al (2011) Zn(++) binding disrupts the Asp(23)-Lys(28) salt bridge without altering the hairpin-shaped cross-β Structure of Aβ(42) amyloid aggregates. Biophys J 101:2825–2832. doi: 10.1016/j.bpj.2011.10.023
13. Ovchinnikova OY, Finder VH, Vodopivec I, Nitsch RM, Glockshuber R (2011) The osaka FAD mutation E22Δ leads to the formation of a previously unknown type of amyloid β fibrils and modulates Aβ neurotoxicity. J Mol Biol 408:780–791. doi:10.1016/j.jmb.2011.02.049
14. Paravastu AK, Leapman RD, Yau W-M, Tycko R (2008) Molecular structural basis for polymorphism in alzheimer’s beta-amyloid fibrils. P Natl Acad Sci USA 105:18349–18354. doi:10.1073/pnas.0806270105
15. Schuetz A, Wasmer C, Habenstein B et al (2010) Protocols for the sequential solid-state NMR spectroscopic assignment of a uniformly labeled 25 kDa protein: hET-s(1-227). ChemBioChem 11:1543–1551. doi:10.1002/cbic.201000124
16. Schütz AK, Vagt T, Huber M et al (2015) Atomic-resolution three-dimensional structure of amyloid β fibrils bearing the osaka mutation. Angew Chem Int Ed Engl 54:331–335. doi:10.1002/anie.201408598
17. Selkoe DJ (1991) The molecular pathology of alzheimer’s disease. Neuron 6:487–498. doi:10.1016/0896-273(91)90052-2
18. Selkoe DJ (1994) Alzheimer’s disease: a central role for amyloid. J Neuropathol Exp Neurol 53:438–447. doi:10.3349/ymj.2014.55.3.689
19. Stevens TJ, Fogh RH, Boucher W et al (2011) A software framework for analysing solid-state MAS NMR data. J Biomol NMR 51:437–447. doi:10.1007/s10858-011-9569-2
20. Vranken WF, Boucher W, Stevens TJ et al (2005) The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59:687–696. doi:10.1002/prot.20449
21. Wälti MA, Orts J, Vögeli B et al (2015) Solution NMR studies of recombinant Aβ(1-42): from the presence of a micellar entity to residual β-sheet structure in the soluble species. ChemBioChem 16:659–669. doi:10.1002/cbic.201402595
22. Wang Y, Jardetzky O (2002) Probability-based protein secondary structure identification using combined NMR chemical-shift data. Protein Sci 11:852–861
23. Wishart DS, Sykes BD (1994) The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data. J Biomol NMR 4:171–180. doi:10.1007/BF00175245
24. Xiao Y, Ma B, McElheny D et al (2015) Aβ 1-42 fibril structure illuminates self-recognition and replication of amyloid in alzheimer’s disease. Nat Struct Mol Biol 22:1–9. doi:10.1038/nsmb.2991